A phase 2 study of a fixed combination of uracil and ftorafur and leucovorin given orally in a twice-daily regimen to treat patients with recurrent metastatic breast cancer.

Hortobagyi, Gabriel N; Young, Robyn R; Karwal, Mark; Ibrahim, Nuhad K; Hermann, Robert; Murray, James L; Watkins, Stanley P; Gore, Ira

Hortobagyi, Gabriel N; Young, Robyn R; Karwal, Mark; Ibrahim, Nuhad K; Hermann, Robert; Murray, James L; Watkins, Stanley P; Gore, Ira.

Affiliation

Hortobagyi GN; Department of Breast Medical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas 77030-4009, USA. ghortoba@mdanderson.org

Cancer ; 116(10): 2301-6, 2010 May 15.

Article in En | MEDLINE | ID: mdl-20225231

Subject(s)

Antineoplastic Combined Chemotherapy Protocols/therapeutic use; Breast Neoplasms/drug therapy; Administration, Oral; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols/adverse effects; Breast Neoplasms/pathology; Drug Administration Schedule; Female; Humans; Leucovorin/administration & dosage; Male; Middle Aged; Neoplasm Metastasis; Recurrence; Tegafur/administration & dosage; Uracil/administration & dosage

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms / Antineoplastic Combined Chemotherapy Protocols Limits: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: Cancer Year: 2010 Type: Article Affiliation country: United States

Fulltext

XML

PubMed Links

Search on Google